Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive localized esophagogastric adenocarcinoma – Interim Analysis of the phase II PHERFLOT/IKF-053 trial of the AIO study group (AIO STO 0321)